A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma.
Engert A, Diehl V, Schnell R, Radszuhn A, Hatwig MT, Drillich S, Schön G, Bohlen H, Tesch H, Hansmann ML, Barth S, Schindler J, Ghetie V, Uhr J, Vitetta E.
Engert A, et al. Among authors: ghetie v.
Blood. 1997 Jan 15;89(2):403-10.
Blood. 1997.
PMID: 9002941
Free article.
Clinical Trial.